NPI: 1902177181 · MAGNOLIA, AR 71753 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 01/20/2012
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 01/20/2012 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 13,542 | $99K |
| 2019 | 13,063 | $117K |
| 2020 | 13,429 | $108K |
| 2021 | 11,529 | $121K |
| 2022 | 11,918 | $138K |
| 2023 | 8,465 | $116K |
| 2024 | 3,451 | $49K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 26,123 | 1,940 | $241K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 26,296 | 1,411 | $158K |
| 82108 | 368 | 335 | $113K | |
| 83970 | 917 | 681 | $77K | |
| 82728 | 526 | 471 | $50K | |
| J1270 | Injection, doxercalciferol, 1 mcg | 12,528 | 1,019 | $38K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 420 | 213 | $16K |
| 83540 | 517 | 457 | $12K | |
| A4657 | Syringe, with or without needle, each | 1,337 | 1,233 | $10K |
| 85041 | 1,294 | 1,099 | $9K | |
| 83550 | 453 | 401 | $8K | |
| 85048 | 1,295 | 1,099 | $7K | |
| 90662 | 21 | 12 | $3K | |
| J1756 | Injection, iron sucrose, 1 mg | 2,894 | 711 | $3K |
| G0008 | Administration of influenza virus vaccine | 74 | 57 | $2K |
| 90674 | 21 | 12 | $737.00 | |
| 85045 | 131 | 113 | $0.00 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 182 | 121 | $0.00 |